This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cardica Takes Off on Bullish Initiation

Stocks in this article: CRDC ISRG

NEW YORK ( TheStreet) -- Shares of Cardica (CRDC) continued to rally on Monday, rising for a second straight session following a bullish analyst initiation.

Wedbush Morgan started coverage of the Redwood City, Calif.-based medical device maker on Friday with an outperform rating and an estimated per share fair valuation of $4. The firm cited optimism about the company's upcoming Microcutter multi-fire endoscopic stapling device, saying it believes Cardica's so-called "staple on a strip" technology "holds best-in-class potential."

"The Microcutter is unique in being able to deploy up to 9 rows of staples without needing a refill, while existing devices can only deploy a single row of staples before a laborious refill process is needed," Wedbush told clients. "Moreover, the Microcutter's much smaller profile is also unique in that it can be used in the next-generation of minimally-invasive surgical procedures, such as single-port surgery."

The stock jumped 49 cents, or 17.4%, to finish at $3.30. That surge follows a gain of 16.1% on Friday. Monday's session high of $3.52 was a new 52-week peak and the stock's best level since mid-February 2009. Volume totaled around 815,000, roughly 13 times the issue's trailing three-month daily average of 62,000. Based on Monday's regular session close, the shares are up more than 140% so far in 2010.

The Microcutter is still in clinical trials. Wedbush Morgan expects the first version of the device, which the company says will be used for bariatric (weight loss), thoracic (which involves cardiac procedures and other organs in the chest) as well as general surgery, to secure European Union approval in the first quarter of 2011 and U.S. approval in the second quarter. The firm estimates sales of this first version, Microcutter ES8, could total $52.9 million by fiscal 2015.

Wedbush's theory is that revenue from the company's other products will provide "valuable" near-term cash flow that will go towards defraying costs related to Microcutter's development and funding the infrastructure of the company, whose saleforce currently consists of just two employees.

Further out, the firm expects the company could end up an acquisition target as soon as late next year.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs